For the year ending 2025-12-31, TVTX has $605,191K in assets. $490,363K in debts. $93,035K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 93,035 | |||
| Marketable debt securities, at fair value | 229,761 | |||
| Accounts receivable, net | 80,134 | |||
| Inventory | 5,875 | |||
| Prepaid expenses and other current assets | 28,760 | |||
| Total current assets | 437,565 | |||
| Long-term inventory | 30,280 | |||
| Property and equipment, net | 4,022 | |||
| Operating lease right-of-use assets | 10,576 | |||
| Intangible assets, net | 113,868 | |||
| Other assets | 8,880 | |||
| Total assets | 605,191 | |||
| Accounts payable | 24,800 | |||
| Accrued expenses | 126,035 | |||
| Convertible debt, current portion | 0 | |||
| Operating lease liabilities, current portion | 5,875 | |||
| Other current liabilities | 3,194 | |||
| Total current liabilities | 159,904 | |||
| Convertible debt, less current portion | 311,724 | |||
| Operating lease liabilities, less current portion | 11,134 | |||
| Other non-current liabilities | 7,601 | |||
| Total liabilities | 490,363 | |||
| Common stock 0.0001 par value 200,000,000 shares authorized 90,922,868 and 87,452,835 issued and outstanding as of december 31, 2025 and 2024, respectively | 9 | |||
| Additional paid-in capital | 1,588,721 | |||
| Accumulated deficit | -1,472,713 | |||
| Accumulated other comprehensive loss | -1,189 | |||
| Total stockholders' equity | 114,828 | |||
| Total liabilities and stockholders' equity | 605,191 | |||
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)